First Light Asset Management’s Heron Therapeutics HRTX Stock Holding History

First Light Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-691,400	Closed	-$8.12M	–	63
2020 Q1	$8.12M	Sell	691,400 -389,759	-36%	-$7.33M	1.39%	24
2019 Q4	$25.4M	Sell	1,081,159 -9,951	-0.9%	-$220K	3.25%	12
2019 Q3	$20.2M	Sell	1,091,110 -7,613	-0.7%	-$140K	3.05%	13
2019 Q2	$20.4M	Sell	1,098,723 -14,243	-1%	-$285K	2.84%	13
2019 Q1	$27.2M	Buy	1,112,966 +287,697	+35%	+$7.53M	3.53%	8
2018 Q4	$21.4M	Sell	825,269 -7,732	-0.9%	-$213K	3.41%	12
2018 Q3	$26.4M	Sell	833,001 -3,736	-0.4%	-$139K	4.25%	7
2018 Q2	$32.5M	Buy	836,737 +363,462	+77%	+$11.6M	5.06%	7
2018 Q1	$13.1M	Buy	473,275 +59,554	+14%	+$1.35M	2.87%	14
2017 Q4	$7.49M	Buy	413,721 +20,216	+5%	+$330K	2.05%	18
2017 Q3	$6.36M	Buy	393,505 +26,115	+7%	+$410K	2.01%	17
2017 Q2	$5.09M	Buy	367,390 +3,701	+1%	+$53.6K	1.71%	23
2017 Q1	$5.46M	Buy	+363,689	New	+$5.03M	2.08%	19

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Light Asset Management's HRTX Position: Q2 2020 in Review

First Light Asset Management sold out of Heron Therapeutics (HRTX) in Q2 2020, closing a stake of 691,400 shares — an estimated $8.12M sold.

First Light Asset Management first reported a position in HRTX in Q1 2017 and held it in 13 quarters. The position peaked at $32.5M in Q2 2018. 190 funds tracked by Wall St. Rank hold HRTX as of Q2 2020.

First Light Asset Management reported no remaining Heron Therapeutics position as of Q2 2020 after selling out during the quarter.
First Light Asset Management sold 691,400 Heron Therapeutics shares in Q2 2020, an estimated $8.12M.
First Light Asset Management first reported a position in Heron Therapeutics in Q1 2017 and held it in 13 quarters.
First Light Asset Management's Heron Therapeutics position peaked at $32.5M in Q2 2018.
190 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2020.

Based on First Light Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.